Projects and Grants per year
Personal profile
Education/Academic qualification
Master of Science, University Of North Carolina
2001
Post Doctoral Fellow, Duke University
2001
Residency, University Of Rochester
1998
Doctor of Medicine, Medical College of Ohio
1995
Bachelor of Science, Bowling Green State University
1990
-
A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphobl
Badgett, J. (PI), Bayliff, S. (Former CoI), D'Orazio, J. (Former CoI), Geil, J. (Former CoI), Radulescu, V. (Former CoI), Shaw, A. (Former CoI) & Sorge, C. (Former CoI)
6/28/19 → 9/7/25
Project: Research project
-
An Open-Label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)
Badgett, J. (PI), Bayliff, S. (CoI), D'Orazio, J. (CoI), Geil, J. (CoI), Sorge, C. (CoI), Radulescu, V. (Former PI) & Shaw, A. (Former CoI)
Childrens Hospital of Philadelphia
12/4/19 → 3/9/22
Project: Research project
-
AHOD1822: An Open-Label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)
Badgett, J. (PI), Bayliff, S. (CoI), D'Orazio, J. (CoI), Geil, J. (CoI), Sorge, C. (CoI), Radulescu, V. (Former PI) & Shaw, A. (Former CoI)
12/4/19 → 2/15/23
Project: Research project
-
Residual Scope: A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients
Badgett, J. (PI), Bayliff, S. (Former CoI), D'Orazio, J. (Former CoI), Geil, J. (Former CoI), Radulescu, V. (Former CoI), Shaw, A. (Former CoI) & Sorge, C. (Former CoI)
6/28/19 → 11/10/22
Project: Research project
-
A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphobl
Badgett, J. (PI), Bayliff, S. (Former CoI), D'Orazio, J. (Former CoI), Geil, J. (Former CoI), Radulescu, V. (Former CoI), Shaw, A. (Former CoI) & Sorge, C. (Former CoI)
Childrens Hospital of Philadelphia
6/28/19 → 1/13/22
Project: Research project